Literature DB >> 31934175

The upregulation of miR-101 promotes vascular endothelial cell apoptosis and suppresses cell migration in acute coronary syndrome by targeting CDH5.

Simin Cao1, Li Li1, Xuebin Geng1, Yi Ma1, Xu Huang2, Xiaoli Kang1.   

Abstract

MicroRNAs (miRNAs) have been reported to be of great importance in a wide range of physiological and pathological processes, including acute coronary syndrome (ACS). However, the exact role of miRNAs in the pathogenesis of ACS has not been fully elucidated. In this study, we found that miR-101 was significantly upregulated in the serum samples of patients with acute coronary syndrome compared with healthy controls. In human umbilical vein endothelial cells (HUVECs), the overexpression of miR-101 drastically promoted cell apoptosis and inhibited cell migration. Mechanistically, miR-101 repressed the expression of CHD5 by targeting its 3'-untranslated region (3'UTR). The silencing of CHD5 also induced cell apoptosis and suppressed cell migration in HUVECs. Taken together, our findings suggest that the miR-101-CHD5 axis may play an important role in the biological behaviors of endothelial cells during the pathogenesis of ACS and may afford an effective diagnostic marker and a powerful therapy for this disease. IJCEP
Copyright © 2019.

Entities:  

Keywords:  Acute coronary syndrome; apoptosis; endothelial cells; miR-101; migration

Year:  2019        PMID: 31934175

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  2 in total

1.  Melatonin upregulates DNA-PKcs to suppress apoptosis of human umbilical vein endothelial cells via inhibiting miR-101 under H2O2-induced oxidative stress.

Authors:  Hao Gu; Jian Li; Rongrong Zhang
Journal:  Mol Cell Biochem       Date:  2020-11-23       Impact factor: 3.396

2.  CTRP15 promotes macrophage cholesterol efflux and attenuates atherosclerosis by increasing the expression of ABCA1.

Authors:  Wei-Hua Tan; Zheng-Liang Peng; Ting You; Zhi-Lu Sun
Journal:  J Physiol Biochem       Date:  2022-03-14       Impact factor: 5.080

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.